M&A Deal Summary

Nabi Biopharmaceuticals Acquires Univax Biologics

On November 29, 1995, Nabi Biopharmaceuticals acquired life science company Univax Biologics

Acquisition Highlights
  • This is Nabi Biopharmaceuticals’ 1st transaction in the Life Science sector.
  • This is Nabi Biopharmaceuticals’ 1st transaction in the United States.
  • This is Nabi Biopharmaceuticals’ 1st transaction in Maryland.

M&A Deal Summary

Date 1995-11-29
Target Univax Biologics
Sector Life Science
Buyer(s) Nabi Biopharmaceuticals
Deal Type Add-on Acquisition

Target

Univax Biologics

Rockville, Maryland, United States
Univax Biologics, Inc., founded in 1988, is a biopharmaceutical company engaged in the development and marketing of products that prevent and treat autoimmune and infectious diseases and related complications through activation and targeting of the human immune system.

Search 191,421 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Nabi Biopharmaceuticals

Rockville, Maryland, United States

website


Category Company
Founded 1967
Sector Life Science
Employees16
DESCRIPTION

Nabi Biopharmaceuticals (NABI) has a broad product portfolio that modulates the immune system. Their research focuses on developing and commercializing novel vaccines and antibody-based therapies that prevent and treat infectious, autoimmune and addictive diseases, such as Staphylococcus aureus and hepatitis infections, and nicotine addiction.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Maryland) 1 of 1
Country (United States) 1 of 1
Year (1995) 1 of 1